Efficacy and Effectiveness of TMS Part 2:Key Studies on TMS for Depression

---

---

Transcranial Magnetic Stimulation (TMS) is one of the most thoroughly researched non-invasive brain therapies in psychiatry. Over the past 15 years, multiple studies have confirmed its effectiveness, safety, and real-world value—especially for people with treatment-resistant depression.

Here are five of the most influential studies that helped establish TMS as a trusted and evidence-based treatment for major depressive disorder (MDD).

1. O’Reardon et al. (2007) – The Landmark Trial Behind FDA Approval

This was the first large, multi-site trial to prove that TMS could effectively treat depression. It included 301 patients across 23 centers, all of whom had not improved with antidepressant medications.

The study was double-blind and sham-controlled—which means that neither the patients nor the doctors knew who was receiving the real TMS treatment and who was getting a fake version designed to mimic it. This helped eliminate bias and ensured that the results were based purely on the treatment’s effectiveness—not patient or provider expectations.

• Key Finding: After 4–6 weeks, patients who received real TMS had significantly higher response rates. About 24% reached full remission, compared to just 12% in the sham group.
• Impact: These results were instrumental in the FDA’s 2008 approval of TMS for depression. It proved that TMS had real, measurable clinical benefits—even when patients had failed multiple medications.

2. Carpenter et al. (2012) – Real-World Clinical Effectiveness

Unlike many tightly controlled studies, this was a naturalistic observational study, meaning it measured outcomes in actual outpatient clinics, where providers treated patients as they normally would—not as part of a research experiment.

This study followed over 300 patients who received TMS in routine clinical settings.

• Key Finding: About 58% of patients showed a significant reduction in symptoms, and 37% achieved remission, even though most had already tried several antidepressants.
• Impact: This study showed that TMS works not just in research labs, but in everyday psychiatric practice. It helped convince both insurers and clinicians that TMS is viable in real-world treatment plans.

3. George et al. (2010) – Long-Term Durability and Maintenance

This study, funded by the National Institutes of Health (NIH), looked at what happens after the initial course of TMS is finished. It tracked patients over a full 18-week period, including a 12-week follow-up after treatment ended.

• Key Finding: Over 60% of patients maintained their improvement, especially those who stayed on antidepressants or received occasional “booster” TMS sessions.
• Impact: This research helped shape the model of maintenance TMS, where patients can return for periodic sessions to help keep symptoms from returning. It reassured both providers and patients that TMS results could last—and that there are options if symptoms start creeping back.

4. Cole et al. (2020) – Stanford’s SAINT Protocol

This study introduced the SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy) protocol, which aimed to treat severe depression much faster than traditional TMS.

Instead of spreading treatment over six weeks, SAINT compressed it into five days, delivering 50 short sessions using advanced targeting based on each patient’s brain scan.

• Key Finding: An astonishing 79% of participants achieved remission, even though they had failed an average of six previous antidepressants.
• Impact: The results captured global attention and launched new interest in accelerated TMS protocols. This study suggested that with the right targeting and schedule, TMS might not just be effective—but life-changing within days for patients in crisis.

5. Berlim et al. (2014) – Meta-Analysis of 29 Randomized Trials

This was a meta-analysis, which is a type of study that combines data from multiple high-quality trials to look at overall trends and reliability. In this case, the authors analyzed 29 randomized, double-blind, sham-controlled studies involving over 1,300 patients with depression.

• Key Finding: High-frequency TMS over the left dorsolateral prefrontal cortex was consistently effective. Patients receiving active TMS were significantly more likely to improve than those receiving sham.
• Impact: Meta-analyses like this one help confirm that TMS works not just in isolated cases, but consistently across studies, clinics, and patient groups. It gave the treatment even more credibility among scientists, policy makers, and insurers.

Final Thoughts

These landmark studies helped move TMS from an experimental concept to a frontline treatment for people with difficult-to-treat depression. Whether in controlled trials or busy clinics, the findings show that TMS consistently helps patients feel better—often when nothing else has worked.

They also taught us how to keep improving: from long-term maintenance options to high-speed treatment protocols, the science behind TMS continues to evolve in exciting ways.

References

1. O’Reardon, J. P., Solvason, H. B., Janicak, P. G., Sampson, S., Isenberg, K. E., Nahas, Z., … & Sackeim, H. A. (2007). Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biological Psychiatry, 62(11), 1208–1216. https://doi.org/10.1016/j.biopsych.2007.01.018
2. Carpenter, L. L., Janicak, P. G., Aaronson, S. T., Boyadjis, T., Brock, D. G., Cook, I. A., … & Demitrack, M. A. (2012). Transcranial magnetic stimulation for major depression: A multisite, naturalistic, observational study. Depression and Anxiety, 29(7), 587–596. https://doi.org/10.1002/da.21969
3. George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., … & Sackeim, H. A. (2010). Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Archives of General Psychiatry, 67(5), 507–516. https://doi.org/10.1001/archgenpsychiatry.2010.46
4. Cole, E. J., Stimpson, K. H., Bentzley, B. S., Gulser, M., Cherian, K., Tischler, C., … & Williams, N. R. (2020). Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression. American Journal of Psychiatry, 177(8), 716–726. https://pubmed.ncbi.nlm.nih.gov/32252538/
5. Berlim, M. T., Van den Eynde, F., Tovar-Perdomo, S., & Daskalakis, Z. J. (2014). Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis. Psychological Medicine, 44(3), 489–498. https://doi.org/10.1017/S0033291713000512

Locations

Choose the office that’s most convenient for you. Our Chesterfield and Richmond Heights locations are here to provide accessible, patient-focused care in a welcoming and professional environment.

CHESTERFIELD
112 Chesterfield Commons East Rd.
Chesterfield, MO 63005
314-697-4867

RICHMOND HEIGHTS
1505 S Big Bend Blvd,
Richmond Heights, MO 63117
314-384-1006